Brainstorm Cell Therapeutics Inc. (BCLI)

Cost of Revenue

$46.00K

Quarterly · Period ending: · USD

BCLI logo

BCLI Cost of Revenue

Latest reported$46.00K
BCLI Quarterly Cost of Revenue ($0.00 → $46.00K)
High-resolution chart · PNG

BCLI cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
46,000
37,000
48,000
0
0
52,000
53,000
59,000
64,000
64,000
66,000
65,000
0
0
70,000
0
0
0
70,000
67,000
0
0
0
0
0
8,308,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
615,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63,350
8,350
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.